Over in the USA, the Federal Trade Congress is holding a workshop exploring whether paediatric gender affirming care is miss-sold / sold via deception. As I understand it, the line up comprises of gender critical medics, detransitioners and families negatively impact.
It doesn’t appear to be a balanced event, exploring different perspectives and does appear to be politically motivated / Trumpian. I view this as a shame because I think the issue warrants proper exploration of all perspectives.
Back in the day, in the UK, access to physical treatment for what is now considered physically ‘transitioning’ (only available to adults) was dependent on a psych evaluation confirming that the patient understood they were their natal sex and that treatment didn’t change this. Failure to recognise this was seen as indicative of the need for a different type of treatment.
I don’t think many ‘transitioners’ seeking treatment actually have a delusional disorder. I think most know they are the sex they are and this isn’t open to change (they tend to remain preoccupied and hyper vigilant and about ‘passing’). I think the miss-selling element is the failure of ‘treatment providers’ to disclose this.
In the UK, the issue presents itself in terms of informed consent more than an issue than miss-selling. I think informed consent to treatment requires clarity in communicating that the treatment will not result in the law, other people or yourself believing you have become a different sex. It will change your appearance and/or your body’s endocrine balance. I think failure to point this out is miss-selling/ deceptive.
The workshop (9th July) will be streamed. It’ll be interesting to see the nature of the arguments presented